Predictors of Hospital Readmission in Patients Receiving Outpatient Parenteral Antimicrobial Therapy

Laura Means, Susan Bleasdale, Monica Sikka, Alan E. Gross

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Study Objective: Outpatient parenteral antimicrobial therapy (OPAT) is increasingly used, and unfortunately, readmissions during OPAT are common. The purpose of this study was to identify predictors of hospital readmission among patients receiving OPAT. Design: Retrospective cohort study. Setting: Large academic tertiary care hospital. Patients: A total of 216 adults who were discharged and received OPAT through a peripherally inserted central catheter for at least 2 days for treatment of an active infection, excluding patients with cystic fibrosis, between January 2012 and August 2013. Of these patients, 43 had hospital readmissions and 173 did not. Measurements and Main Results: The median age of all study patients was 56 years. Common infections included bone and joint (32%), genital/urinary tract (16%), endocarditis (14%), central nervous system (9.7%), and pneumonia (9.7%). For the 43 patients (20%) who had readmissions, reasons for readmission were infection recurrence or progression (33%), adverse drug reactions (24%), central catheter–associated issues (16%), or non-OPAT–related reasons (27%). In the multivariate analysis, patients assigned to a primary care physician were less likely to be readmitted (odds ratio [OR] 0.286, 95% confidence interval [CI] 0.115–0.711), whereas factors independently associated with an increased readmission rate included previous hospital admission in the past 12 months (OR 2.588, 95% CI 1.159–5.778), medical history of malignant lymphoma (OR 25.172, 95% CI 2.311–272.209), and increased planned OPAT duration (OR 1.058, 95% CI 1.034–1.082). Conclusion: Readmissions while patients received OPAT were common. Therefore, proactive interventions including primary care physician assignment to facilitate follow-up and communication should be implemented to decrease the risk of readmission, particularly in the identified high-risk populations.

Original languageEnglish (US)
Pages (from-to)934-939
Number of pages6
JournalPharmacotherapy
Volume36
Issue number8
DOIs
StatePublished - Aug 1 2016
Externally publishedYes

Fingerprint

Patient Readmission
Outpatients
Odds Ratio
Confidence Intervals
Primary Care Physicians
Therapeutics
Infection
Tertiary Healthcare
Endocarditis
Drug-Related Side Effects and Adverse Reactions
Urinary Tract
Tertiary Care Centers
Cystic Fibrosis
Lymphoma
Pneumonia
Cohort Studies
Multivariate Analysis
Catheters
Central Nervous System
Retrospective Studies

Keywords

  • antimicrobial management
  • OPAT
  • readmission

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Predictors of Hospital Readmission in Patients Receiving Outpatient Parenteral Antimicrobial Therapy. / Means, Laura; Bleasdale, Susan; Sikka, Monica; Gross, Alan E.

In: Pharmacotherapy, Vol. 36, No. 8, 01.08.2016, p. 934-939.

Research output: Contribution to journalArticle

Means, Laura ; Bleasdale, Susan ; Sikka, Monica ; Gross, Alan E. / Predictors of Hospital Readmission in Patients Receiving Outpatient Parenteral Antimicrobial Therapy. In: Pharmacotherapy. 2016 ; Vol. 36, No. 8. pp. 934-939.
@article{26d3400d5f2b436e8ff7e38a9808a6c6,
title = "Predictors of Hospital Readmission in Patients Receiving Outpatient Parenteral Antimicrobial Therapy",
abstract = "Study Objective: Outpatient parenteral antimicrobial therapy (OPAT) is increasingly used, and unfortunately, readmissions during OPAT are common. The purpose of this study was to identify predictors of hospital readmission among patients receiving OPAT. Design: Retrospective cohort study. Setting: Large academic tertiary care hospital. Patients: A total of 216 adults who were discharged and received OPAT through a peripherally inserted central catheter for at least 2 days for treatment of an active infection, excluding patients with cystic fibrosis, between January 2012 and August 2013. Of these patients, 43 had hospital readmissions and 173 did not. Measurements and Main Results: The median age of all study patients was 56 years. Common infections included bone and joint (32{\%}), genital/urinary tract (16{\%}), endocarditis (14{\%}), central nervous system (9.7{\%}), and pneumonia (9.7{\%}). For the 43 patients (20{\%}) who had readmissions, reasons for readmission were infection recurrence or progression (33{\%}), adverse drug reactions (24{\%}), central catheter–associated issues (16{\%}), or non-OPAT–related reasons (27{\%}). In the multivariate analysis, patients assigned to a primary care physician were less likely to be readmitted (odds ratio [OR] 0.286, 95{\%} confidence interval [CI] 0.115–0.711), whereas factors independently associated with an increased readmission rate included previous hospital admission in the past 12 months (OR 2.588, 95{\%} CI 1.159–5.778), medical history of malignant lymphoma (OR 25.172, 95{\%} CI 2.311–272.209), and increased planned OPAT duration (OR 1.058, 95{\%} CI 1.034–1.082). Conclusion: Readmissions while patients received OPAT were common. Therefore, proactive interventions including primary care physician assignment to facilitate follow-up and communication should be implemented to decrease the risk of readmission, particularly in the identified high-risk populations.",
keywords = "antimicrobial management, OPAT, readmission",
author = "Laura Means and Susan Bleasdale and Monica Sikka and Gross, {Alan E.}",
year = "2016",
month = "8",
day = "1",
doi = "10.1002/phar.1799",
language = "English (US)",
volume = "36",
pages = "934--939",
journal = "Pharmacotherapy",
issn = "0277-0008",
publisher = "Pharmacotherapy Publications Inc.",
number = "8",

}

TY - JOUR

T1 - Predictors of Hospital Readmission in Patients Receiving Outpatient Parenteral Antimicrobial Therapy

AU - Means, Laura

AU - Bleasdale, Susan

AU - Sikka, Monica

AU - Gross, Alan E.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Study Objective: Outpatient parenteral antimicrobial therapy (OPAT) is increasingly used, and unfortunately, readmissions during OPAT are common. The purpose of this study was to identify predictors of hospital readmission among patients receiving OPAT. Design: Retrospective cohort study. Setting: Large academic tertiary care hospital. Patients: A total of 216 adults who were discharged and received OPAT through a peripherally inserted central catheter for at least 2 days for treatment of an active infection, excluding patients with cystic fibrosis, between January 2012 and August 2013. Of these patients, 43 had hospital readmissions and 173 did not. Measurements and Main Results: The median age of all study patients was 56 years. Common infections included bone and joint (32%), genital/urinary tract (16%), endocarditis (14%), central nervous system (9.7%), and pneumonia (9.7%). For the 43 patients (20%) who had readmissions, reasons for readmission were infection recurrence or progression (33%), adverse drug reactions (24%), central catheter–associated issues (16%), or non-OPAT–related reasons (27%). In the multivariate analysis, patients assigned to a primary care physician were less likely to be readmitted (odds ratio [OR] 0.286, 95% confidence interval [CI] 0.115–0.711), whereas factors independently associated with an increased readmission rate included previous hospital admission in the past 12 months (OR 2.588, 95% CI 1.159–5.778), medical history of malignant lymphoma (OR 25.172, 95% CI 2.311–272.209), and increased planned OPAT duration (OR 1.058, 95% CI 1.034–1.082). Conclusion: Readmissions while patients received OPAT were common. Therefore, proactive interventions including primary care physician assignment to facilitate follow-up and communication should be implemented to decrease the risk of readmission, particularly in the identified high-risk populations.

AB - Study Objective: Outpatient parenteral antimicrobial therapy (OPAT) is increasingly used, and unfortunately, readmissions during OPAT are common. The purpose of this study was to identify predictors of hospital readmission among patients receiving OPAT. Design: Retrospective cohort study. Setting: Large academic tertiary care hospital. Patients: A total of 216 adults who were discharged and received OPAT through a peripherally inserted central catheter for at least 2 days for treatment of an active infection, excluding patients with cystic fibrosis, between January 2012 and August 2013. Of these patients, 43 had hospital readmissions and 173 did not. Measurements and Main Results: The median age of all study patients was 56 years. Common infections included bone and joint (32%), genital/urinary tract (16%), endocarditis (14%), central nervous system (9.7%), and pneumonia (9.7%). For the 43 patients (20%) who had readmissions, reasons for readmission were infection recurrence or progression (33%), adverse drug reactions (24%), central catheter–associated issues (16%), or non-OPAT–related reasons (27%). In the multivariate analysis, patients assigned to a primary care physician were less likely to be readmitted (odds ratio [OR] 0.286, 95% confidence interval [CI] 0.115–0.711), whereas factors independently associated with an increased readmission rate included previous hospital admission in the past 12 months (OR 2.588, 95% CI 1.159–5.778), medical history of malignant lymphoma (OR 25.172, 95% CI 2.311–272.209), and increased planned OPAT duration (OR 1.058, 95% CI 1.034–1.082). Conclusion: Readmissions while patients received OPAT were common. Therefore, proactive interventions including primary care physician assignment to facilitate follow-up and communication should be implemented to decrease the risk of readmission, particularly in the identified high-risk populations.

KW - antimicrobial management

KW - OPAT

KW - readmission

UR - http://www.scopus.com/inward/record.url?scp=84983078734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983078734&partnerID=8YFLogxK

U2 - 10.1002/phar.1799

DO - 10.1002/phar.1799

M3 - Article

C2 - 27393717

AN - SCOPUS:84983078734

VL - 36

SP - 934

EP - 939

JO - Pharmacotherapy

JF - Pharmacotherapy

SN - 0277-0008

IS - 8

ER -